The White House dropped Dr. Heidi Overton's nomination to lead the Food and Drug Administration on Tuesday.
The decision came a day before the Senate Health Committee was scheduled to vote on advancing her nomination. The move followed weeks of doubts from key Republicans, including committee chairman Sen. Bill Cassidy, who had questioned Overton's experience and pressed on abortion-related issues before remaining undecided. Cassidy criticized the White House for pulling the nomination, saying it abandoned a viable confirmation path and withdrew Overton rather than give final assurances sought by pro-life senators. With Democrats set to take the Senate in early January, filling the FDA post permanently now may fall to Senate Democrats.